1,3-dipropyl-8-(4-sulfophenyl)xanthine has been researched along with caffeine in 14 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 5 (35.71) | 18.7374 |
1990's | 6 (42.86) | 18.2507 |
2000's | 3 (21.43) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Daly, JW; Padgett, WL; Shamim, MT; Ukena, D | 1 |
Butts-Lamb, P; Daly, JW; Padgett, W; Shamim, MT; Waters, J | 1 |
Jacobson, KA; Ji, XD; Kim, HO; Melman, N; Olah, ME; Stiles, GL | 1 |
Daly, JW; Gallo-Rodriguez, C; Jacobson, KA; Kiriasis, L; Manning, M; Müller, C; Neumeyer, JL; Pfleiderer, W; Shi, D | 1 |
Bellows, DS; Clarke, ID; Diamandis, P; Dirks, PB; Graham, J; Jamieson, LG; Ling, EK; Sacher, AG; Tyers, M; Ward, RJ; Wildenhain, J | 1 |
Branch, KR; Jackson, EK; Magee, WD; Oliver, RD; Tofovic, SP | 1 |
Biaggioni, I; Feoktistov, I; Hollister, AS; Paul, S; Robertson, D | 1 |
Biaggioni, I; Branch, RA; Jackson, EK; Paul, S; Robertson, D | 1 |
Holycross, BJ; Jackson, EK; Li, P | 1 |
Jackson, EK; Kuan, CJ; Wells, JN | 1 |
Kuan, CJ; Tarng, JL; Tseng, CJ; Tung, CS | 1 |
Lobo, MG; Oliveira, DG; Ribeiro, JA; Sebastião, AM | 1 |
Carcillo, JA; Jackson, EK; Tofovic, SP; Zacharia, L | 1 |
Albino-Teixeira, A; Carvalho, F; Fernandes, E; Laranjinha, J; Morato, M; Nunes, C; Pinho, D; Sousa, T | 1 |
14 other study(ies) available for 1,3-dipropyl-8-(4-sulfophenyl)xanthine and caffeine
Article | Year |
---|---|
Effects of 8-phenyl and 8-cycloalkyl substituents on the activity of mono-, di-, and trisubstituted alkylxanthines with substitution at the 1-, 3-, and 7-positions.
Topics: Adenylyl Cyclases; Adipose Tissue; Adrenal Gland Neoplasms; Animals; Blood Platelets; Brain; Caffeine; Chemical Phenomena; Chemistry; Humans; Molecular Structure; Phenylisopropyladenosine; Pheochromocytoma; Rats; Receptors, Purinergic; Structure-Activity Relationship; Theophylline; Tumor Cells, Cultured; Xanthines | 1989 |
1,3-Dialkyl-8-(p-sulfophenyl)xanthines: potent water-soluble antagonists for A1- and A2-adenosine receptors.
Topics: Adenosine; Animals; Cerebral Cortex; In Vitro Techniques; Rats; Receptors, Cell Surface; Receptors, Purinergic; Solubility; Structure-Activity Relationship | 1985 |
Structure-activity relationships of 1,3-dialkylxanthine derivatives at rat A3 adenosine receptors.
Topics: Adenosine; Adenylyl Cyclase Inhibitors; Animals; Brain; Brain Chemistry; Caffeine; CHO Cells; Cricetinae; Gene Expression; Iodine Radioisotopes; Molecular Structure; Phenethylamines; Phenylisopropyladenosine; Rats; Receptors, Purinergic P1; Structure-Activity Relationship; Transfection; Xanthines | 1994 |
Effect of trifluoromethyl and other substituents on activity of xanthines at adenosine receptors.
Topics: Acylation; Alkylation; Animals; Brain; Caffeine; Cell Membrane; Cyclization; Molecular Structure; Purinergic P1 Receptor Antagonists; Rats; Receptors, Purinergic P1; Structure-Activity Relationship; Trifluoroacetic Acid; Xanthines | 1993 |
Chemical genetics reveals a complex functional ground state of neural stem cells.
Topics: Animals; Cell Survival; Cells, Cultured; Mice; Molecular Structure; Neoplasms; Neurons; Pharmaceutical Preparations; Sensitivity and Specificity; Stem Cells | 2007 |
Caffeine potentiates vasodilator-induced renin release.
Topics: Adenosine; Analysis of Variance; Animals; Blood Pressure; Caffeine; Chromatography, High Pressure Liquid; Drug Synergism; Hydralazine; Male; Rats; Rats, Inbred Strains; Receptors, Purinergic; Renin; Xanthines | 1991 |
Adenosine inhibits the rise in intracellular calcium and platelet aggregation produced by thrombin: evidence that both effects are coupled to adenylate cyclase.
Topics: Adenosine; Adenosine-5'-(N-ethylcarboxamide); Adenylyl Cyclases; Caffeine; Calcium; Cytosol; Humans; Platelet Aggregation; Platelet Aggregation Inhibitors; Thrombin; Xanthines | 1990 |
Caffeine potentiates the renin response to furosemide in rats. Evidence for a regulatory role of endogenous adenosine.
Topics: Adenosine; Animals; Caffeine; Drug Synergism; Furosemide; Kidney; Male; Rats; Rats, Inbred Strains; Renin; Xanthines | 1989 |
Adenosine-angiotensin II interactions. Part II. The role of adenosine in regulating angiotensin II-induced changes in heart rate and aldosterone release.
Topics: Adenosine; Aldosterone; Angiotensin II; Animals; Blood Pressure; Caffeine; Heart Rate; Male; Rats; Rats, Inbred Strains; Xanthines | 1989 |
Role of endogenous adenosine as a modulator of the renin response to salt restriction.
Topics: Adenosine; Animals; Caffeine; Diet, Sodium-Restricted; Glomerular Filtration Rate; Humans; Male; Potassium; Rats; Rats, Inbred Strains; Receptors, Purinergic; Renal Circulation; Renin; Sodium; Xanthines | 1987 |
Effect of adenosine blockade on plasma renin activity and catecholamines.
Topics: Adenosine; Animals; Blood Pressure; Caffeine; Consciousness; Epinephrine; Hydralazine; Kidney; Male; Norepinephrine; Perfusion; Rats; Rats, Sprague-Dawley; Receptors, Purinergic P1; Renin; Renin-Angiotensin System; Secretory Rate; Sodium, Dietary; Theophylline; Xanthines | 1993 |
On the high affinity of 8-cyclohexylcaffeine for the presynaptic inhibitory adenosine receptor present in rat motor nerve terminals.
Topics: 2-Chloroadenosine; Animals; Caffeine; Electric Stimulation; Female; In Vitro Techniques; Male; Neuromuscular Junction; Presynaptic Terminals; Purinergic P1 Receptor Antagonists; Rats; Rats, Wistar; Xanthines | 1997 |
Inhibition of adenosine deaminase attenuates endotoxin-induced release of cytokines in vivo in rats.
Topics: Adenine; Adenosine; Adenosine Deaminase; Adenosine Deaminase Inhibitors; Animals; Blood Pressure; Caffeine; Catecholamines; Cytokines; Endotoxemia; Endotoxins; Enzyme Inhibitors; Heart; Heart Rate; Male; Propranolol; Purinergic P1 Receptor Antagonists; Rats; Rats, Sprague-Dawley; Renin; Xanthines | 2001 |
Scavenging of nitric oxide by an antagonist of adenosine receptors.
Topics: Adenosine A2 Receptor Antagonists; Animals; Caffeine; Dose-Response Relationship, Drug; Free Radical Scavengers; Male; Nitrates; Nitric Oxide; Nitrites; Rats; Rats, Wistar; Receptor, Adenosine A1; Xanthines | 2005 |